Xenon Pharmaceuticals Inc (NASDAQ: XENE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT XENON PHARMACEUTICALS INC

Xenon Pharmaceuticals Inc (NASDAQ: XENE)
Listen to this Section


$53.43
+1.1290 ( +2.16% ) 968.8K

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Market Data


Open $53.43
Previous Close $52.30
Volume 968.8K
Market Cap $5.06B
Day Range $51.72 - $54.50
52 Week Range $29.74 - $63.95
Shares Outstanding 96.67M
Change % +2.16%
Net Change ▲ 1.1290
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2014
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 63 Nov 03, 2025
8-k 8K-related 12 Nov 03, 2025
4 Insider transactions 1 Oct 17, 2025
3 Insider transactions 2 Oct 17, 2025
8-k/a 8K-related 16 Oct 17, 2025
8-k 8K-related 16 Oct 16, 2025
4 Insider transactions 1 Oct 01, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 68 Aug 11, 2025
8-k 8K-related 10 Jul 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy